Equity Capital And Reserves Zmiana Data
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
ALKERMES USD 1.36B 75.15M 2023-09
BioCryst Pharmaceuticals USD -410986000 22.27M 2023-09
Biogen USD 14.8B 315.6M 2023-12
Bristol-Myers Squibb USD 29B 2.98B 2023-09
Cytokinetics USD -386323000 52.48M 2023-12
Esperion Therapeutics USD -410004000 38.03M 2023-09
Gilead Sciences USD 22.75B 435M 2023-12
Halozyme Therapeutics USD 83.81M 165.37M 2023-12
Intra Cellular Therapies USD 591.42M 9.26M 2023-12
J&J USD 71.23B 3.92B 2023-09
Marinus Pharmaceuticals USD 54.54M 2.8M 2023-09
Minerva Neurosciences USD -20046000 7.53M 2023-09
Nektar Therapeutics USD 159.37M 37.59M 2023-09
Neurocrine Biosciences USD 2B 149.1M 2023-09
RedHill Biopharma USD 3.47M 1.47M 2023-06
Supernus Pharmaceuticals USD 921.52M 9.32M 2023-12
United Therapeutics USD 5.98B 272.7M 2023-12
Vanda Pharmaceuticals USD 539.9M 4.16M 2023-06



Intra Cellular Therapies Kapitał Własny I Rezerwy - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.